Trades on 1 secondary market

Excision Biotherapeutics

Excision BioTherapeutics is a clinical-stage biotechnology company developing CRISPR-based gene-editing therapies intended to functionally cure serious viral infectious diseases. Its programs use multiplexed CRISPR/Cas approaches delivered via adeno-associated virus (AAV) to excise latent viral DNA

minimal 7.7 / 100 0 APIs View provider profile →

Company Biotechnology Gene Editing CRISPR Therapeutics Infectious Disease

Excision Biotherapeutics is an API provider whose private shares are listed on 1 secondary market: EquityZen.

Where It Trades

EZ EquityZen View listing →

Listing data is compiled from the public marketplace pages of Forge Global, Hiive, EquityZen, Nasdaq Private Market, and Augment. A listing indicates that a venue has published a page for this company — it is not an offer, a quote, or investment advice, and APIs.io has no affiliation with any venue.